We serve Chemical Name:3-(Cyanoacetyl)-1-methylindole CAS:343778-74-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:3-(Cyanoacetyl)-1-methylindole
CAS.NO:343778-74-5
Synonyms:3-(1-methylindol-3-yl)-3-oxopropanenitrile
Molecular Formula:C12H10N2O
Molecular Weight:198.22100
HS Code:2933990090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:423.5ºC at 760 mmHg
Density:1.14 g/cm3
Index of Refraction:1.602
PSA:45.79000
Exact Mass:198.07900
LogP:2.27468
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 3-(1-methylindol-3-yl)-3-oxopropanenitrile chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-(1-methylindol-3-yl)-3-oxopropanenitrile physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-(1-methylindol-3-yl)-3-oxopropanenitrile Use and application,3-(1-methylindol-3-yl)-3-oxopropanenitrile technical grade,usp/ep/jp grade.
Related News: Secretary of Health Francisco Duque said authorities are working with the Chinese embassy to respectfully handle the remains of the man while following international protocol to contain the disease. 3-(Cyanoacetyl)-1-methylindole manufacturer On April 8, a group of employees filed an anonymous complaint internally alleging that an executive at its Branchburg, New Jersey, factory had altered documents required by the U.S. Food and Drug Administration. 3-(Cyanoacetyl)-1-methylindole supplier Under the terms of this agreement, Inceptua will support Onconova through the pre-approval provision of intravenous rigosertib initially into a number of countries including: Australia, Denmark, Finland, France, Ireland, Italy, the Netherlands, Portugal, South Africa, Spain, and the UK. 3-(Cyanoacetyl)-1-methylindole vendor Lilly has pledged to address the problems, and said none of them affected drugs in the market. The FDA, which has taken no public action, did not respond to requests for comment. 3-(Cyanoacetyl)-1-methylindole factory On April 8, a group of employees filed an anonymous complaint internally alleging that an executive at its Branchburg, New Jersey, factory had altered documents required by the U.S. Food and Drug Administration.
